Todos Medical Ltd. TOMDF
Set alert
At close · Oct 29
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.000001
- Prev close
- 0.00001
- Mkt cap
- 21.30K
- Vol
- 320
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.000001
- High
- 0.000001
News
7 months ago defenseworld.net
Todos Med (OTCMKTS:TOMDF) and Aclarion (NASDAQ:ACON) Head-To-Head Survey
Aclarion (NASDAQ: ACON - Get Free Report) and Todos Med (OTCMKTS:TOMDF - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the…
7 months ago defenseworld.net
Reviewing Todos Med (OTCMKTS:TOMDF) & Auna (NYSE:AUNA)
Auna (NYSE: AUNA - Get Free Report) and Todos Med (OTCMKTS:TOMDF - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength…
10 months ago defenseworld.net
Financial Analysis: GeneDx (NASDAQ:WGS) & Todos Med (OTCMKTS:TOMDF)
Todos Med (OTCMKTS:TOMDF - Get Free Report) and GeneDx (NASDAQ: WGS - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the…
2 years ago globenewswire.com
Todos Medical Announces Insolvency Proceedings in Israel
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, Israel, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), an innovative healthcare solutions company, today…
3 years ago globenewswire.com
Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Sept. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Todos Medical, Ltd. (OTCQB: TOMDF), an innovative healthcare solutions company, today provided…
3 years ago globenewswire.com
Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients
Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad's lifelong work NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Aug. 30, 2023 (GLOBE NEWSWIRE) --…
3 years ago proactiveinvestors.com
Todos Medical enters LOI for Provista Diagnostics to license key PCR-based sepsis diagnostic test
Todos Medical Ltd. (OTCQB:TOMDF) announced it has entered into a letter of intent (LOI) with Acumen Diagnostics of Singapore for its CLIA/CAP-certified clinical testing lab Provista Diagnostics to…
3 years ago proactiveinvestors.com
Todos Medical expresses support for Long COVID sufferers, plans to study Tollovid's usefulness in patients
Todos Medical Ltd CEO Gerald Commissiong has shared the company's aim to open a prospective study to confirm the usefulness of its dietary supplement Tollovid in cases of Long COVID. The CEO…
3 years ago proactiveinvestors.ca
Todos Medical updates investors on its lab Provista Diagnostics, subsidiary 3CL Pharma, and Todos Botanicals automated retail rollout
Todos Medical Ltd has provided investors with an update on its corporate activities, including its moves to capitalize on the renewed interest in PCR testing to identify patients infected with COVID,…
3 years ago proactiveinvestors.com
Todos Medical says Provista Diagnostics lab kicks off validation plan for PCR-based bird flu test for humans
Todos Medical Ltd. (OTCQB:TOMDF) announced that its CLIA/CAP-certified Provista Diagnostics laboratory has initiated a validation plan for polymerase chain reaction (PCR)-based Avian Influenza A…
3 years ago globenewswire.com
Todos Medical to Present at the RHK 2022 Disruptive Growth Conference
New York, NY, and Tel Aviv, ISRAEL, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today…
3 years ago proactiveinvestors.ca
Todos Medical signs agreement to sell supplements via Affy Services' Smart Automated Retail Network
Todos Medical Ltd (OTCQB:TOMDF) said it has entered into a five-year agreement with Smart Automated Retail Network (SARN) to supply immune support supplements on a worldwide basis. Smart Automated…
3 years ago proactiveinvestors.ca
Todos Medical finds major 3Q revenue bump from COVID-19 testing services
Todos Medical Ltd reported third-quarter financial results that showed a surge in revenue and narrowing operating loss. The company posted revenue of $1.9 million in the three months ended September…
3 years ago globenewswire.com
Todos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022
NEW YORK, NY, AND TEL AVIV, ISRAEL, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today…
4 years ago proactiveinvestors.com
Todos Medical clinical laboratory Provista Diagnostics submits emergency use application for its PCR monkeypox test
Todos Medical Ltd announced that its clinical laboratory Provista Diagnostics Inc has filed an Emergency Use Authorization (EUA) application with the US Food & Drug Administration for its PCR…
4 years ago proactiveinvestors.com
Todos Medical pursuing New York Stock Exchange listing, it says in a wide-ranging update into new business developments
Todos Medical Ltd told investors it was seeking a New York Stock Exchange listing and revealed it is in the final stages of launching a crowdfunding campaign for its subsidiary 3CL Pharma and its…
4 years ago proactiveinvestors.ca
Todos Medical touts successful pilot launch of suite of PCR testing services by its lab Provista Diagnostics
Todos Medical Ltd revealed that its CLIA/CAP accredited lab Provista Diagnostics has successfully completed a pilot launch of a suite of polymerase chain reaction (PCR) testing services in the rural…
4 years ago proactiveinvestors.ca
Todos Medical set to be granted two patents for its TBIA pan-cancer blood diagnostics platform
Todos Medical Ltd has welcomed news it will be granted two patents covering its total biochemical infrared analysis (TBIA) fourier transformed infrared (FTIR) pan-cancer blood diagnostics platform.…
4 years ago proactiveinvestors.ca
Todos Medical announces receipt of notice of allowance for its 3CL protease biomarker diagnostics TolloTest
Todos Medical Ltd said its majority-owned joint venture 3CL Pharma Ltd has received a notice of allowance issued by the US patent and trademark office for its TolloTest. The test is designed to…
4 years ago proactiveinvestors.ca
Todos Medical strikes $50M contact with Nerd Hemp to distribute Tollovid and CBD products in AI retail machines across the US
Todos Medical Ltd announced it has signed a contract worth $50 million with CBD retail distributor Nerd Hemp Inc to supply its lead product Tollovid and botanical '0% THC' CBD products in pill,…